Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMGN Amgen

Not Yet Opened 06-04 16:00:00 EDT

345.60

+7.38

+2.18%

盘后346.98

+1.38+0.40%

19:53 EDT

High349.18	Low342.25	Vol2.91M
Open345.87	D1 Closing338.22	Amplitude2.05%
Mkt Cap186.10B	Tradable Cap185.59B	Total Shares538.48M
T/O1.00B	T/O Rate0.54%	Tradable Shares536.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"Amgen","latestPrice":345.6,"timestamp":1780603200000,"preClose":338.22,"halted":0,"volume":2907057,"hourTrading":{"tag":"盘后","latestPrice":346.9839,"preClose":345.6,"latestTime":"19:53 EDT","volume":85798,"amount":29653275.6909,"timestamp":1780617231533,"change":1.3839,"changeRate":0.004004,"amplitude":0.004004},"delay":0,"changeRate":0.021820117083555066,"floatShares":536994627,"shares":538480671,"eps":14.368346,"marketStatus":"Not Yet Opened","change":7.38,"latestTime":"06-04 16:00:00 EDT","open":345.87,"high":349.18,"low":342.25,"amount":1003068680.3277,"amplitude":0.02049,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":14.368346,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780646400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":338.22,"dividendRate":0.027951,"preHourTrading":{"tag":"盘前","latestPrice":346,"preClose":338.22,"latestTime":"09:29 EDT","volume":5472,"amount":1876742.34624,"timestamp":1780579799999,"change":7.78,"changeRate":0.023003,"amplitude":0.023003},"postHourTrading":{"tag":"盘后","latestPrice":346.9839,"preClose":345.6,"latestTime":"19:53 EDT","volume":85798,"amount":29653275.6909,"timestamp":1780617231533,"change":1.3839,"changeRate":0.004004,"amplitude":0.004004},"volumeRatio":1.311523,"impliedVol":0.2279,"impliedVolPercentile":0.1434},"requestUrl":"/m/hq/s/AMGN","defaultTab":"news","newsList":[{"id":"2641516403","title":"Amgen to present at Goldman Sachs Global Healthcare Conference webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2641516403","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641516403?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:01","pubTimestamp":1780603301,"startTime":"0","endTime":"0","summary":"Amgen will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026 at 9:20 a.m. ET.Executive vice president and CFO Peter Griffith will speak alongside executive vice president Murdo Gordon.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLbYRksD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU1791807156.HKD","LU0320765992.SGD","LU2112291526.USD","LU1057294990.SGD","LU1868836757.USD","LU1868836591.USD","LU1894683264.USD","LU0868494617.USD","IE00B19Z3581.USD","LU0251131958.USD","LU2750360997.AUD","LU1023059063.AUD","LU1868837136.USD","IE0002270589.USD","LU2471134952.CNY","LU1571399168.USD","BK4552","BK4566","GSX","BK4139","BK4127","LU0058720904.USD","AMGN","LU2237443382.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","SG9999001440.SGD","LU2237443622.USD","BK4534","LU2471134523.USD","LU0889565916.HKD","IE0009355771.USD","BK4599","LU1868836914.USD","IE00B2B36J28.USD","LU0345770308.USD","IE00BJJMRZ35.SGD","BK4516","LU0251142724.SGD","LU1983299246.USD","IE00BFXG1179.USD","IE00B4R5TH58.HKD","LU1668664300.SGD","BK4585","LU2471134796.USD","LU0289739699.SGD","LU0122379950.USD","BK4581","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168283490","title":"Movement Alert｜Amgen Rises 3.01% in Regular Trading, EU Approves Its Small Cell Lung Cancer Drug Imdylltra","url":"https://stock-news.laohu8.com/highlight/detail?id=1168283490","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168283490?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:07","pubTimestamp":1780582023,"startTime":"0","endTime":"0","summary":"On June 4, Amgen rose 3.01% in regular trading, trading at $346.7/share, with trading volume of $106 million.On the news front, the European Commission officially approved Amgen's Imdylltra® for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640580431","title":"Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640580431","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640580431?lang=en_us&edition=fundamental","pubTime":"2026-06-04 16:33","pubTimestamp":1780561980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.5% to 4.70 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.5% to 25253.40.This was the stock's fourth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 48% below its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 103.0 million shares, compared to the 50-day average of 79.7 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IE0009355771.USD","LU1571399168.USD","IE0002141913.USD","AMGN","BK4566","IE00BZ08YT58.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0289739699.SGD","LU1061106388.HKD","BK1521","BK4533","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU2112291526.USD","BK4588","LU1057294990.SGD","HK0000165453.HKD","LU0868494617.USD","BK1515","LU2089984988.USD","LU2242652126.USD","LU0109394709.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU2242646821.SGD","01177","IE00B2B36J28.USD","LU0122379950.USD","BK4585","IE00BZ08YR35.GBP","BK1589","LU0320765992.SGD","LU1983299246.USD","BK4139","BK1191","LU0889565916.HKD","IE00BZ08YS42.EUR","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640341841","title":"Assessing Amgen (AMGN) Valuation After Imdelltra Approval And Concerns Over Tavneos And Prolia","url":"https://stock-news.laohu8.com/highlight/detail?id=2640341841","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640341841?lang=en_us&edition=fundamental","pubTime":"2026-06-04 13:29","pubTimestamp":1780550981,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) is in focus after a packed stretch of product and earnings news, including European approval for Imdelltra in small cell lung cancer and fresh concerns around Tavneos and Prolia that weighed on sentiment.\nSee our latest analysis for Amgen.\nAt a share price of $338.22, Amgen has a 1-day share price return of 3.03% and a 30-day share price return of 4.44%, while the 90-day share price return is down 7.99%. This hints at cooling momentum despite a 1-year total shareholder return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/assessing-amgen-amgn-valuation-after-imdelltra-approval-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/assessing-amgen-amgn-valuation-after-imdelltra-approval-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1057294990.SGD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","SG9999001440.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0889565916.HKD","BK4533","IE0009355771.USD","BK4588","LU0320765992.SGD","LU2089984988.USD","LU0289739699.SGD","LU1023059063.AUD","LU2242652126.USD","BK4585","BK4566","LU2112291526.USD","LU0868494617.USD","IE00B2B36J28.USD","AMGN","LU1983299246.USD","BK4581","IE0002141913.USD","BK4139","LU2468319806.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4534","LU1571399168.USD","BK4599","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640187881","title":"Amgen CEO Bradway says AI reshapes drug discovery and development","url":"https://stock-news.laohu8.com/highlight/detail?id=2640187881","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640187881?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:11","pubTimestamp":1780524716,"startTime":"0","endTime":"0","summary":"Amgen CEO Bob Bradway told Bain’s Winning with AI podcast that AI is reshaping biotechnology, with broad impact across the drug lifecycle.Bradway said the company invested early in AI and data science, positioning it to apply the technology across its operations.He framed AI as a catalyst for change in how medicines are discovered, developed, manufactured, and delivered to patients.The interview focused on scaling organizational transformation to support wider AI deployment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL8c854b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4581","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4139","LU1571399168.USD","LU2242652126.USD","LU0889565916.HKD","IE00B2B36J28.USD","BK4599","LU2089984988.USD","LU2242646821.SGD","BK4585","IE0009355771.USD","LU1057294990.SGD","BK4588","BK4566","LU1061106388.HKD","LU0868494617.USD","LU2112291526.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4533","BK4534","SG9999001440.SGD","AMGN","LU0058720904.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640843811","title":"Amgen Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2640843811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640843811?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:35","pubTimestamp":1780518900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 3.03% to $338.22 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.74% to 7,553.68 and Dow Jones Industrial Average  falling 1.21% to 50,687.07.The stock's rise snapped a two-day losing streak.Amgen Inc. closed 13.56% below its 52-week high of $391.29, which the company reached on March 2nd.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 0.16% to $223.24, Pfizer Inc.  fell 0.82% to $25.34, and AbbVie Inc.  rose 0.80% to $217.13.Trading volume  remained 240,975 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","LU1061106388.HKD","LU1571399168.USD","LU0868494617.USD","LU0058720904.USD","LU2468319806.SGD","BK4581","BK4599","IE0009355771.USD","LU1983299246.USD","BK4533","LU1057294990.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU2242652126.USD","BK4534","IE00BFTCPJ56.SGD","BK4588","LU0122379950.USD","SG9999001440.SGD","LU2242646821.SGD","BK4139","LU0109394709.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0320765992.SGD","BK4566","AMGN","04332","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121293380","title":"Movement Alert｜Amgen Rises 3.06% in Regular Trading, EU Approves Its Small Cell Lung Cancer Drug Imdylltra","url":"https://stock-news.laohu8.com/highlight/detail?id=1121293380","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121293380?lang=en_us&edition=fundamental","pubTime":"2026-06-04 03:57","pubTimestamp":1780516653,"startTime":"0","endTime":"0","summary":"On June 4, Amgen rose 3.06% in regular trading, trading at $338.39/share, with trading volume of $498 million.On the news front, the European Commission officially approved Amgen's Imdylltra® for the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640907880","title":"EU approves Amgen’s Imdylltra for advanced small-cell lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640907880","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640907880?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:29","pubTimestamp":1780493380,"startTime":"0","endTime":"0","summary":"European Commission granted marketing authorization for Amgen’s Imdylltra  to treat adults with advanced small-cell lung cancer post platinum chemotherapy.Phase 3 DeLLphi-304 showed a 40% reduction in death risk versus chemotherapy; median overall survival 13.6 months versus 8.3 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL66l1WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU1571399168.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU2468319806.SGD","LU0122379950.USD","LU0058720904.USD","LU2112291526.USD","BK4534","LU0109394709.USD","BK4588","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4566","BK4585","LU1057294990.SGD","BK4533","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4581","BK4139","LU0868494617.USD","BK4599","LU0889565916.HKD","IE0009355771.USD","LU0289739699.SGD","LU2242652126.USD","AMGN","IE0002141913.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","IE00B2B36J28.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640897579","title":"EU Approval Of IMDYLLTRA Puts Amgen’s Lung Cancer Ambitions In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2640897579","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640897579?lang=en_us&edition=fundamental","pubTime":"2026-06-03 12:52","pubTimestamp":1780462336,"startTime":"0","endTime":"0","summary":"European Commission approves Amgen's IMDYLLTRA (tarlatamab) for adults with extensive-stage small cell lung cancer as a second-line treatment.\nDecision follows positive Phase 3 results showing a survival benefit over standard chemotherapy.\nApproval adds a new marketed therapy to Amgen's oncology portfolio in a high unmet medical need area.\n\nFor investors following Amgen (NasdaqGS:AMGN), the European Commission's green light for IMDYLLTRA arrives with the stock trading around $328.26. Shares...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/eu-approval-of-imdylltra-puts-amgens-lung-cancer-ambitions-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/eu-approval-of-imdylltra-puts-amgens-lung-cancer-ambitions-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BJJMRZ35.SGD","LU0289739699.SGD","BK4585","LU2089984988.USD","LU0889565916.HKD","SG9999001440.SGD","IE0009355771.USD","IE0002141913.USD","LU0868494617.USD","BK4156","IE00B2B36J28.USD","BK4581","BK4588","LU0122379950.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU2242652126.USD","BK4599","BK4534","BK4566","LU0320765992.SGD","LU1983299246.USD","BK4533","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","LU2468319806.SGD","AMGN","LU0058720904.USD","LU2242646821.SGD","BK4139","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640422189","title":"Health Rounds: Radiation-emitting implant improves outcomes after brain cancer surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2640422189","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640422189?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:55","pubTimestamp":1780419315,"startTime":"0","endTime":"0","summary":"Health Rounds: Radiation-emitting implant improves outcomes after brain cancer surgeryHealth Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidJune 2  - Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL1N4290MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689514.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU1043141396.HKD","LU1585245621.USD","LU2505996681.GBP","BK4534","SG9999002232.USD","SG9999013999.USD","LU2491050154.USD","LU0640476718.USD","IE00BBT3K403.USD","LU1061106388.HKD","LU2023250504.SGD","LU2324357040.USD","BK4548","LU2023250330.USD","LU2461242641.AUD","LU0070302665.USD","LU0861579265.USD","IE0002270589.USD","LU1116320737.USD","LU1430594728.SGD","LU1934455194.USD","LU1868837300.USD","LU0237698245.USD","SG9999002224.SGD","LU1069347547.HKD","LU0208291251.USD","LU0225284248.USD","LU0289739699.SGD","LU1989772840.SGD","IE00BFTCPJ56.SGD","LU1989772923.USD","LU0868494708.USD","LU0648001328.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1074936037.SGD","BK4533","IE000SO60NU8.SGD","LU2417539215.USD","LU2125154935.USD","LU1035773651.USD","LU0795875086.SGD","LU1974910355.USD","LU0096364046.USD","BK4532","LU0114720955.EUR","LU0985320562.USD","BK4581","LU1894683264.USD","LU1201861249.SGD","LU1267930813.SGD","LU2347655156.SGD","LU0942090050.USD","LU2487616109.SGD","LU0426417589.USD","LU2112291526.USD","LU0477156953.USD","IE00BKVL7J92.USD","LU0994945656.USD","LU0912757837.SGD","LU0225771236.USD","LU0345769128.USD","LU1929549753.HKD","LU0683600562.USD","LU2357627491.SGD","LU2456880835.USD","LU0889566641.SGD","LU0965509283.SGD","LU0122379950.USD","LU0820561909.HKD","BK4588","BK4566","LU1280957306.USD","LU2750360641.GBP","IE00BVYPNW00.USD","LU1244550577.SGD","LU1032955483.USD","LU1059921491.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU0426412945.USD","LU2133065610.SGD","LU2756315318.SGD","LU1674673691.USD","LU0130517989.USD","LU0058720904.USD","LU1699723380.USD","LU2125154778.USD","LU1941712264.USD","MRNA","LU1670711123.USD","LU1162221912.USD","LU2471134879.HKD","BK4599","LU0321505868.SGD","LU1066051225.USD","LU2403377893.USD","LU1551013342.USD","SG9999001176.USD","LU0109394709.USD","LU0980610538.SGD","IE00B19Z3B42.SGD","LU1221951046.USD","LU2242646821.SGD","LU2471134523.USD","MRNY","LU0265550359.USD","IE00BVYPNV92.GBP","BK4585","LU0859254822.USD","LU2750360997.AUD","LU2592432038.USD","IE000WAW04H5.SGD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU2125909247.SGD","LU2430703251.USD","LU0965508806.USD","SG9999014559.SGD","LU0320765992.SGD","IE0002141913.USD","BK4516","LU0965509101.SGD","LU0306807586.USD","LU0985481810.HKD","IE00BSNM7G36.USD","IE000BZT7R73.USD","LU1093756168.USD","LU1228905037.USD","LU1935042991.SGD","IE00B4R5TH58.HKD","LU0320765646.SGD","BK4559","LU0545562505.USD","LU1571399168.USD","IE00B7SZLL34.SGD","SG9999001176.SGD","BK4568","LU0689472784.USD","JNJ","LU1868836591.USD","LU1868836757.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0889565916.HKD","LU2430703095.HKD","LU1989771016.USD","LU2129689431.USD","LU2471134952.CNY","LU1121112475.USD","LU2491050071.SGD","LU0964807845.USD","SG9999001440.SGD","LU0234570918.USD","LU1670710661.SGD","IE0000B7K699.USD","BMY","MRK","IE00B3PB1722.GBP","LU0203345920.USD","LU1196500208.SGD","LU0098860793.USD","LU0211331839.USD","LU0320765489.SGD","LU0466842654.USD","LU0943347566.SGD","LU1670710588.SGD","LU2471134796.USD","LU1914381329.SGD","SG9999015358.SGD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0203347892.USD","LU2106854487.HKD","LU2213496289.HKD","LU1023059063.AUD","IE00B3T34201.USD","SG9999014567.USD","BK4550","IE00BZ1G4Q59.USD","LU0265550946.USD","LU0345769631.USD","LU1923622614.USD","LU2361044865.SGD","LU2602419157.SGD","LU2236285917.USD","LU0306806265.USD","LU1732799900.SGD","LU1496350502.SGD","LU2505996509.AUD","LU1116320901.HKD","LU0345770993.USD","LU2023250843.SGD","LU1941712348.USD","SG9999014542.SGD","LU0432979614.USD","LU1145028129.USD","LU1868837136.USD","LU1244550221.USD","SG9999014575.USD","IE00BDGV0183.EUR","IE00BLSP4239.USD","IE000MB6IJN5.SGD","LU1066051811.HKD","LU1670711040.USD","LU0234572021.USD","LU1261432733.SGD","BK4139","LU1066053197.SGD","BK4592","LU1244550494.USD","BK4501","LU0130102774.USD","IE00BFXG1179.USD","LU2361044949.HKD","BK4504","LU2756315664.SGD","LU2129689605.HKD","LU0053666078.USD","LU0070217475.USD","LU0787776722.HKD","BK4551","LU0882574055.USD","LU0965509010.AUD","IE00BN8TJ469.HKD","LU0820561818.USD","LU1093756325.SGD","LU1323610961.USD","LU0210528500.USD","LU0124676726.USD","LU1037948897.HKD","BK4007","LU1778281490.HKD","04332","LU0210536198.USD","AMGN","IE00B42XCP33.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","LU0689626769.HKD","LU0868494617.USD","LU1506573853.SGD","LU1894683348.USD","LU1917777945.USD","LU1983299246.USD","LU2430703178.SGD","LU0238689110.USD","LU2468319806.SGD","LU1291159041.SGD","LU2242652126.USD","LU0266013472.USD","LU1551013425.SGD","LU1934455277.USD","LU1674673428.USD","LU0345770308.USD","LU1934455863.HKD","LU2361045086.USD","LU0267386448.USD","MRNX","LU0006306889.USD","LU0792757196.USD","LU0061475181.USD","LU1718418525.SGD","SG9999015341.SGD","IE00B19Z3581.USD","LU2360032135.SGD","LU1228905540.USD","IE0034235303.USD","LU1032466523.USD","LU1732800096.USD","LU2125909593.SGD","LU1057294990.SGD","LU2433249047.HKD","LU2896262040.SGD","LU1037948541.HKD","IE0009355771.USD","LU0106261372.USD","LU0795875169.SGD","LU1868836914.USD","LU0820562030.AUD","LU1629891620.HKD","LU1221951129.SGD","LU1043141123.HKD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640894523","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Thermo Fisher (TMO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640894523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640894523?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:10","pubTimestamp":1780405808,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN) and Thermo Fisher (TMO). Amgen (AMGN) Bernstein anal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-and-thermo-fisher-tmo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-and-thermo-fisher-tmo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0957791311.USD","LU2298321311.HKD","LU0058720904.USD","LU0029874061.USD","BK4599","LU0345770308.USD","XLV","LU0342679015.USD","LU1571399168.USD","LU0320765992.SGD","LU1064131342.USD","LU2242646821.SGD","LU2211814178.USD","LU1923622291.USD","BK4533","LU0070302665.USD","IE0034235188.USD","LU2357305700.SGD","IE00BQXX3C00.GBP","LABU","LU0528227936.USD","LU2764262908.HKD","GB00BDT5M118.USD","XBI","LU0320765489.SGD","IE00BKPKM429.USD","LU2125910336.SGD","LU0122379950.USD","LU2125909916.SGD","LU2125909593.SGD","LU1815333072.USD","LU1712237335.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4139","LU1988902786.USD","LU0868494617.USD","LU0432979614.USD","LU2063271972.USD","HCSG","AMGN","TMO","IE0002141913.USD","LU0128526141.USD","LU0061474960.USD","LU2360108059.USD","IE00BQXX3F31.USD","LU2125910179.SGD","LU2112291526.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915131","title":"Sino Biopharmaceutical Stock Slides 1.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640915131?lang=en_us&edition=fundamental","pubTime":"2026-06-02 16:33","pubTimestamp":1780389180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 4.88 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 2.5% to 26038.32.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 46% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 70.0 million shares, compared to the 50-day average of 78.9 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU1571399168.USD","LU2242646821.SGD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BZ08YS42.EUR","LU0058720904.USD","LU1023059063.AUD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00B2B36J28.USD","BK4533","LU2468319806.SGD","BK4139","LU2089984988.USD","LU2112291526.USD","BK4588","LU1057294990.SGD","BK4581","BK1191","IE00BZ08YT58.USD","IE0009355771.USD","LU2242652126.USD","SG9999001440.SGD","AMGN","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK1515","BK4599","LU0289739699.SGD","LU0889565916.HKD","LU0109394709.USD","BK1589","BK1521","BK4585","01177","IE00BZ08YR35.GBP","LU1983299246.USD","HK0000165453.HKD","IE00BFTCPJ56.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640992089","title":"Healthcare and 2 Other Lagging Sectors to Buy -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2640992089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640992089?lang=en_us&edition=fundamental","pubTime":"2026-06-02 14:00","pubTimestamp":1780380000,"startTime":"0","endTime":"0","summary":"The stock market's rally has left out several sectors that are becoming truly attractive.Those sectors -- healthcare, financial and utilities -- have been in the shadow of the Big Tech companies that have pushed the indexes higher in 2026. The S&P 500 has gained 11% this year, driven by the VanEck Semiconductor ETF, up 69%. A few manufacturers such as Eaton and Vertiv Holdings have also boosted the broader market.These companies are seeing exploding demand for products that build the data centers that the Big Tech services companies are investing in to house their artificial intelligence technology.Also, let's not forget Apple's 13% gain for the year. It's hit a $4 trillion market capitalization, helping lift the S&P 500.But only 283 stocks on the index were up for the year, as of late Monday morning, according to FactSet. That left 220 stocks in the red for 2026 -- and even more that were underperforming.The overall revenue growth for the sector will help profit margins rise -","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4566","XLF","XLV","IE00B4R5TH58.HKD","BK4581","BK4585","LU1621767737.EUR","IE0034235188.USD","SG9999001440.SGD","LU1894683348.USD","LU0868494617.USD","SMH","STT","LABU","BK4534","LU2089984988.USD","IE000M9KFDE8.USD","LU1057294990.SGD","IE00B2B36J28.USD","AMGN","LU1621768206.USD","FDN","LU2362541513.USD","LU2468319806.SGD","LU2242652126.USD","LU1621767810.EUR","BK4599","LU2463526074.USD","LU0058720904.USD","LU2362540622.SGD","BK4588","HCSG","XBI","IE0002141913.USD","IE00BGHQF748.EUR","LU0061475181.USD","DUK","LU2242646821.SGD","LU1621768115.EUR","IE00B29SXK94.USD","BK4081","LU2384288077.EUR","IE0009355771.USD","IE00B29SXL02.USD","LU1983299246.USD","BK4535","LU1244550577.SGD","LU0122379950.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962692","title":"European Commission approves Amgen’s Imdylltra for ES-SCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962692","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962692?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:35","pubTimestamp":1780346114,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced that the European Commission has granted marketing authorization for Imdylltra as a monotherapy to treat adults with extensi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/european-commission-approves-amgens-imdylltra-for-es-sclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/european-commission-approves-amgens-imdylltra-for-es-sclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4534","IE0002141913.USD","LU0289739699.SGD","AMGN","IE00B4R5TH58.HKD","LU0889565916.HKD","LU2089984988.USD","LU2637428348.USD","LU2468319806.SGD","IE0009355771.USD","LU1880398554.USD","LU2112291526.USD","SG9999001440.SGD","IE00B29SXL02.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1023059063.AUD","LU0109394709.USD","EPV","IE00BZ18W340.USD","LU0122379950.USD","IE00B2B36J28.USD","IE00BMG7P694.USD","IE00BZ18W456.USD","LU0058720904.USD","LU1571399168.USD","LU1803068623.USD","LU0868494617.USD","BK4533","IE00B29SXK94.USD","LU1057294990.SGD","IE00BMQBXF63.USD","BK4081","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2242646821.SGD","LU1983299246.USD","IE00BMG7P819.SGD","BK4585","LU1880398471.USD","ES","IE00BMG7P926.USD","LU1883839398.USD","LU2242652126.USD","BK4139","BK4566","BK4588","IE00BMG7P587.USD","LU2449327464.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962849","title":"Amgen Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962849?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:35","pubTimestamp":1780346100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slid 2.27% to $329.13 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.26% to 7,599.96 and the Dow Jones Industrial Average  rising 0.09% to 51,078.88.The stock's fall snapped a three-day winning streak.Amgen Inc. closed 15.89% short of its 52-week high of $391.29, which the company reached on March 2nd.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.81% to $223.51, Pfizer Inc.  fell 2.10% to $25.63, and AbbVie Inc.  fell 2.20% to $212.93.Trading volume  remained 570,928 below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street J","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGRO","DDM","IE0009355771.USD","IE00B2B36J28.USD","LU1983299246.USD","LU1061106388.HKD","FDN","LU2112291526.USD","GRNY","LU0058720904.USD","LU2242652126.USD","AMGN","LU1023059063.AUD",".DJI","BK4533","DGRW","BK4534","VYMI","MGK","04332","LU2089984988.USD","LU0122379950.USD","TOPT","BK4566","SCHG","YMAX","BK4585","DVY","LU0868494617.USD","SDY","UDOW","DJX","IE0002141913.USD","FDVV","SCHD","LU1571399168.USD","IE00B4R5TH58.HKD","BK4139","LU0289739699.SGD","IE00BFTCPJ56.SGD","DOG","SG9999001440.SGD","BK4599","VUG","XLI","LU1057294990.SGD","BK4581","DJIA","MYMmain","LU0109394709.USD","VYM","DIA","LU2242646821.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","SDOW","LU0889565916.HKD","LU0320765992.SGD","LU2468319806.SGD","BK4588","DXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640648899","title":"EU grants Amgen approval for Imdylltra in extensive-stage small cell lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640648899","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640648899?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:01","pubTimestamp":1780344075,"startTime":"0","endTime":"0","summary":"European Commission granted marketing authorization for Amgen’s IMDYLLTRA  to treat adults with extensive-stage small cell lung cancer post platinum chemotherapy.Approval was based on Phase 3 DeLLphi-304, showing a 40% lower risk of death versus chemotherapy; median overall survival 13.6 months vs 8.3.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief via PR Newswire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLcdvbBl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU2089984988.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE0002141913.USD","BK4139","IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","LU0058720904.USD","IE00B2B36J28.USD","LU2242652126.USD","BK4581","BK4599","LU2468319806.SGD","LU0122379950.USD","LU1571399168.USD","BK4566","LU2112291526.USD","LU1057294990.SGD","BK4533","BK4534","BK4588","LU1061106388.HKD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0868494617.USD","AMGN","LU1023059063.AUD","LU2242646821.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640196108","title":"European Commission Approves Amgen's Imdylltra® for the Treatment of Extensive-Stage Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640196108","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640196108?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:00","pubTimestamp":1780344000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA2F9Y1M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","IE0002141913.USD","LU1061106388.HKD","LU0320765992.SGD","LU2468319806.SGD","BK4534","SG9999001440.SGD","LU1571399168.USD","LU0289739699.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4599","LU2112291526.USD","AMGN","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4533","LU1057294990.SGD","BK4588","BK4581","LU2089984988.USD","BK4139","LU0058720904.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0889565916.HKD","LU1983299246.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU2242646821.SGD","IE0009355771.USD","LU0868494617.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158485165","title":"Movement Alert｜Amgen Falls 3.02% in Regular Trading, FDA Proposes Withdrawal of Rare Disease Drug Over Fatal Liver Injury Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=1158485165","media":"Market Focus","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158485165?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:20","pubTimestamp":1780327207,"startTime":"0","endTime":"0","summary":"On June 1, Amgen fell 3.02% in regular trading, trading at $326.35/share, with trading volume of $171 million.On the news front, the U.S. Food and Drug Administration has proposed revoking market...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988328","title":"Mabwell Bioscience proposes new board slate as four directors retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988328","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988328?lang=en_us&edition=fundamental","pubTime":"2026-05-31 19:55","pubTimestamp":1780228533,"startTime":"0","endTime":"0","summary":"Mabwell proposed a new board lineup at a June 18, 2026 EGM, setting up leadership continuity under chairman and general manager Liu Datao.Executive director slate includes Liu, founder Tang Chunshan, R&D president Wu Hai, CFO Hua Jun; Gui Xun to be chosen separately as employee director.Retirements planned for Hu Huiguo, Wu Yufeng, Xu Qing, Zhao Qian once new directors are elected; Hu stays as deputy general manager.Wu Hai previously held senior R&D roles at Amgen, Trellis Bioscience; served at Junshi as deputy general manager and director.Hua Jun previously worked in finance roles at GE, Johnson & Johnson, Roche, Hutchison MediPharma; later ran finance and procurement at Henlius.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabwell ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nNDL2sRq5S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","HK0000320264.USD","LU0320765992.SGD","LU1983299246.USD","BK1161","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU2089984988.USD","BK4139","BK0239","LU0109394709.USD","LU0868494617.USD","LU1571399168.USD","LU2468319806.SGD","BK4581","LU1023059063.AUD","BK4566","LU2242652126.USD","02696","HK0000165453.HKD","IE00B2B36J28.USD","00656","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU2112291526.USD","LU0889565916.HKD","SG9999001440.SGD","BK1230","HK0000306685.HKD","BK4533","IE00BJT1NW94.SGD","LU0122379950.USD","LU0289739699.SGD","BK4588","BK4585","LU0058720904.USD","IE00B4R5TH58.HKD","IE0002141913.USD","AMGN","IE0009355771.USD","HK0000320223.HKD","BK4599","BK4534","HK0000306701.USD","688062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672435","title":"Amgen to present at Jefferies Global Healthcare Conference webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672435","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672435?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:01","pubTimestamp":1780084901,"startTime":"0","endTime":"0","summary":"Amgen will present at the Jefferies Global Healthcare Conference on June 4, 2026 at 9:55 a.m. ET.Speakers include CFO Peter Griffith, global development SVP Narimon Honarpour, global marketing and access SVP Kave Niksefat.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL3y1kmV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0122379950.USD","LU1023059063.AUD","BK4588","AMGN","BK4581","LU0109394709.USD","LU0289739699.SGD","LU0058720904.USD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4534","LU1571399168.USD","LU0868494617.USD","LU2112291526.USD","LU0889565916.HKD","IE0002141913.USD","LU2242652126.USD","IE00BJT1NW94.SGD","LU2089984988.USD","BK4585","BK4139","LU1983299246.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2242646821.SGD","LU1061106388.HKD","IE00B2B36J28.USD","BK4566","LU1057294990.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0444},{"period":"3month","weight":-0.0799},{"period":"6month","weight":0.0253},{"period":"1year","weight":0.168},{"period":"ytd","weight":0.0333}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0505},{"period":"3month","weight":0.107},{"period":"6month","weight":0.1},{"period":"1year","weight":0.2653},{"period":"ytd","weight":0.1061}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.","yearOnYearQuotes":[{"month":1,"riseRate":0.651163,"avgChangeRate":0.034336},{"month":2,"riseRate":0.488372,"avgChangeRate":0.00202},{"month":3,"riseRate":0.511628,"avgChangeRate":0.016602},{"month":4,"riseRate":0.44186,"avgChangeRate":-0.003156},{"month":5,"riseRate":0.511628,"avgChangeRate":0.022981},{"month":6,"riseRate":0.511628,"avgChangeRate":0.003884},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.511628,"avgChangeRate":0.002296},{"month":10,"riseRate":0.534884,"avgChangeRate":0.021538},{"month":11,"riseRate":0.627907,"avgChangeRate":0.022348},{"month":12,"riseRate":0.627907,"avgChangeRate":0.045446}],"exchange":"NASDAQ","name":"Amgen","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amgen,AMGN,Amgen股票,Amgen股票老虎,Amgen股票老虎国际,Amgen行情,Amgen股票行情,Amgen股价,Amgen股市,Amgen股票价格,Amgen股票交易,Amgen股票购买,Amgen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}